Ultrahuman Acquires viO HealthTech to Add OvuSense Ovulation Tech
August 15, 2025
Ultrahuman has acquired viO HealthTech and launched Cycle & Ovulation Pro for its Ultrahuman Ring AIR, integrating viO's clinically validated OvuSense ovulation-tracking algorithm into the ring using finger-based temperature sensing. viO's technology — developed over 15 years with FDA 510(k) clearance and CE Class IIa certifications — will be offered as a paid subscription across the US, UK, EU, Canada and Australia. The deal brings clinical-grade women's health capability to Ultrahuman's consumer wearable platform to improve cycle and ovulation insights.
- Buyers
- Ultrahuman
- Targets
- viO HealthTech
- Industry
- Medical Devices
- Location
- Connecticut, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
ŌURA Acquires Veri
September 11, 2024
Healthcare Services
ŌURA, maker of the Oura Ring, entered into an agreement to acquire Veri, a Helsinki-based personalized metabolic health company. Veri’s team and founders will join ŌURA, and the Veri brand is expected to go away by the end of 2024 as its metabolic guidance is folded into ŌURA’s health suite.
-
Labcorp Acquires Ovia Health
August 12, 2021
Healthcare Services
Labcorp acquired Ovia Health, a digital women's health platform that supports family planning, pregnancy and parenting, to expand its women's health capabilities and digital offerings. The acquisition builds on a prior strategic investment from Labcorp's Venture Fund and aims to combine Labcorp's diagnostics and genetics expertise with Ovia's digital platform to improve patient experience and outcomes; terms were not disclosed.
-
Olympus to Acquire Odin Vision
December 20, 2022
Medical Devices
Olympus Corporation has signed a definitive agreement to acquire London-based Odin Vision, a cloud-AI endoscopy company, for up to GBP 66 million in upfront and milestone payments. The purchase is part of Olympus' broader digital strategy to integrate AI-driven detection, diagnostics, and cloud-enabled workflow solutions into its Digital Endosuite to improve clinical decision-making and patient outcomes.
-
EcoVadis Acquires Ulula
September 4, 2024
Data & Analytics
EcoVadis has acquired Ulula, a human-rights technology and analytics company, to integrate Ulula's worker engagement platform and analytics into EcoVadis' sustainability intelligence offerings. The acquisition strengthens EcoVadis' ability to provide on-the-ground, verifiable labor and human-rights data to customers and supports compliance with evolving global supply-chain regulations.
-
Granata Bio Acquires Oviva Therapeutics
April 29, 2025
Biotechnology
Granata Bio has acquired Oviva Therapeutics, a women's health biotech developing OVI-586, a first-in-class therapeutic aimed at extending ovarian function and improving reproductive outcomes. The acquisition expands Granata's fertility and women's health pipeline and will advance OVI-586 toward further development for applications including menopause, contraception, and in vitro fertilization (IVF).
-
Vizgen Acquires Ultivue (Merger to Form Combined Spatial Biology Company)
October 9, 2024
Biotechnology
Vizgen and Ultivue have merged to create a single spatial biology company that combines Vizgen’s MERFISH single-cell spatial genomics platform with Ultivue’s InSituPlex assays and STARVUE proteomic/AI capabilities. Rob Carson (former CEO of Ultivue) will serve as President and CEO of the combined Vizgen, and the transaction was completed alongside Vizgen’s Series D financing backed by investors including ARCH Venture Partners, Northpond Ventures and Tao Capital Partners.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.